Teleflex (TFX) is in discussions to acquire Biotronik SE & Co.’s vascular intervention unit, offering to buy the German medical technology firm’s business for EUR 500M to EUR 1B, people familiar with the matter told Bloomberg’s Sonja Wind, Arno Schuetze, and Eyk Henning. A deal could be reached as soon as this month, one of the sources is reported to have said.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX: